1. Article | 2019.06.18

   Transversal

   Teams from the Department of Structural Biology and Chemistry and from Computational Biology develop new molecules, technologies and approaches to detect and fight AMR.

2. Article | 2019.08.06

   Vaccinology and Immunotherapy Initiative: Innovation – Vaccine Candidates

   The Institut Pasteur has a distinguished history of vaccine development as a means to improve global health. A stronghold of the Institut Pasteur in vaccines is the development of novel technologies for vaccine design and delivery with several candidates currently under clinical evaluation, either licensed to development and commercialization partners or under Institut Pasteur sponsorship.

3. Article | 2019.08.06

   Vaccinology and Immunotherapy Initiative: Clinical Research

   Clinical Research in Vaccinology and Immunotherapy at Institut Pasteur includes clinical studies with the advanced vaccine candidates developed by Institut Pasteur (described as part of the Innovation – Vaccine candidates, immune-monitoring of Institut Pasteur sponsored clinical trials as well as in collaboration with partners, and cohort and surveillance studies to uncover the disease-specific...

4. Article | 2021.08.03

   Understanding mechanisms of brain function

   Department of Cell Biology & InfectionSandrine Etienne-Manneville - Astrocytic responses to inflammatory situationsAstrocytes form the majority of glial cells of the central nervous system. They play a key role in brain homeostasis, they serve as physical and nutritional support for neurons and they directly participate in synaptic transmission. In inflammatory situations, such as...

5. Article | 2019.08.06

   Vaccinology and Immunotherapy Initiative: Fundamental Research

   Many different fields of the highly recognized fundamental research pursued at the Institut Pasteur are connected to vaccinology or immunotherapy. These include pathogen identification and characterization, structural analysis, in silico approaches, analysis of mechanisms to potentially enhance antigen immunogenicity and/or delivery or to identify specific immunotherapy targets, effects of...

6. Article | 2019.06.25

   Vector-pathogen interactions (4 entities)

   Vector-borne diseases play an increasing role among emerging infections. This thematic area explores the complex interactions between vectors and their pathogens, in order to identify ways of blocking infection of the vectors as a novel approach to epidemic control.

7. Article | 2019.06.18

   Vectors

   The vectors, such as insects, are also investigated to develop new strategies to avoid microbes inoculation.

8. Article | 2019.06.18

   Viruses

   Teams of the Department of Virology, of Global Heath, of Structural Biology and Chemistry and of Computational Biology study viruses causing infections to understand their epidemiology and to develop alternative strategies to fight them and overcome drug resistance.

9. News | 2025.02.10

   Training Today’s and Tomorrow’s Scientists for the Challenges of Artificial Intelligence

   Artificial Intelligence (AI) is revolutionizing scientific research, particularly in the life sciences, by facilitating the processing of vast amounts of data and accelerating advancements in computational biology, genomics, and image analysis. Aware of this transformation, the Institut Pasteur has integrated AI into its projects from the outset and is further strengthening this commitment...

10. Page avancée | 2016.09.20

    Education

    Education

Pages